JESSICA MCMAINE: Open Payments
NPI 1093254930 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 103 payments from 17 companies in 2025. Trend: 2023 $1,121 · 2024 $1,260 · 2025 $1,501
Food & beverage: $1,501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $319 |
| Lilly USA, LLC | 11 | $200 |
| Novo Nordisk Inc | 11 | $192 |
| Insulet Corporation | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 9 | $151 |
| GlaxoSmithKline, LLC. | 9 | $144 |
| Abbott Laboratories | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Dexcom, Inc. | 2 | $44 |
Products named: VRAYLAR, Omnipod, TRELEGY ELLIPTA, JARDIANCE, UBRELVY, Rybelsus, AIRSUPRA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
